When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYL - Teva: The Road To Perdition Has Turned Into A Path Towards Redemption
Mylan N.V.
Summary
Only 6.5 months have gone by since we assigned a BUY rating to Teva Pharmaceutical Industries Ltd (TEVA) and the stock hasn't disappointed us.
A total return of 54.1% isn't only a phenomenal return for itself, but it also significantly outperformed the performance of benchmarks such as Health Care Select Sector SPDR® ETF (XLV) or SPDR® S&P 500 ETF Trust (SPY).
Data by YCharts
The recent earnings boosted the stock price by more than 10%. However, the stock has given back the entire post-earnings gain, mostly due to reports regarding 21 States rejecting the